{
    "eid": "2-s2.0-84960086232",
    "title": "Cognitive remission: A novel objective for the treatment of major depression?",
    "cover-date": "2016-01-22",
    "subject-areas": [
        {
            "$": "General Medicine",
            "@code": "2700"
        }
    ],
    "keywords": [
        "Antidepressants",
        "Cognition",
        "Cognitive enhancers",
        "Erythropoietin",
        "Lisdexamfetamine dimesylate",
        "Major depression",
        "Novel targets",
        "Psychiatry",
        "Vortioxetine"
    ],
    "authors": [
        "Beatrice Bortolato"
    ],
    "citedby-count": 181,
    "ref-count": 191,
    "ref-list": [
        "The epidemiology of depression across cultures",
        "Recovery from depression",
        "Disability Mediates the Impact of Common Conditions on Perceived Health",
        "Differences in Mechanism of Action Between Current and Future Antidepressants",
        "A meta-analysis of cognitive deficits in first-episode Major Depressive Disorder",
        "The frequency of cognitive impairment in patients with anxiety, depression, and bipolar disorder: An unaccounted source of variance ie clinical trials",
        "Cognitive deficits in depression: Possible implications for functional neuropathology",
        "Longitudinal assessment of neuropsychological function in major depression",
        "Cognitive impairment in unipolar depression is persistent and non-specific: Further evidence for the final common pathway disorder hypothesis",
        "Cognitive impairment in depression: A systematic review and meta-analysis",
        "Cognitive dysfunction in depression \u2013 Pathophysiology and novel targets",
        "Augmentation strategies for treatment-resistant depression: A literature review",
        "The societal cost of depression: Evidence from 10,000 Swedish patients in psychiatric care",
        "Cognitive deficits and functional outcomes in major depressive disorder: Determinants, substrates, and treatment interventions",
        "Mediators of the association between depression and role functioning",
        "Neurocognitive deficits and disability in major depressive disorder",
        "Executive function improvement upon remission of recurrent unipolar depression",
        "Persistent non-verbal memory impairment in remitted major depression - Caused by encoding deficits?",
        "Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder",
        "The Cognitive Effects of Antidepressants in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Clinical Trials",
        "Executive dysfunction predicts nonresponse to fluoxetine in major depression",
        "Neuropsychological characteristics as predictors of SSRI treatment response in depressed subjects",
        "Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder",
        "Cognitive dysfunction in major depressive disorder: A state-of-the-art clinical review",
        "Relationships among neurocognition, symptoms, and functioning in treatment-resistant depression",
        "Cognition as predictor of current and follow-up depressive symptoms in the general population",
        "Effects of recurrent major depressive disorder on behavior and cognitive function in female depressed patients",
        "Specifying the neuropsychology of affective disorders: Clinical, demographic and neurobiological factors",
        "Association between depression severity and neurocognitive function in major depressive disorder: A review and synthesis",
        "The relationship between neurocognitive and psychosocial functioning in major depressive disorder: A systematic review",
        "Assessment of subjective and objective cognitive function in bipolar disorder: Correlations, predictors and the relation to psychosocial function",
        "Is there an association between subjective and objective measures of cognitive function in patients with affective disorders?",
        "A meta-analysis of executive dysfunctions in unipolar major depressive disorder without psychotic symptoms and their changes during antidepressant treatment",
        "Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: A meta-analysis and review",
        "A meta-analysis of depression severity and cognitive function",
        "Enduring cognitive dysfunction in unipolar major depression: A test-retest study using the Stroop paradigm",
        "Cognitive impairment in the remitted state of unipolar depressive disorder: A systematic review",
        "The cumulative load of depressive illness is associated with cognitive function in the remitted state of unipolar depressive disorder",
        "Cognitive impairment in euthymic major depressive disorder: A meta-analysis",
        "A meta-analysis of cognitive functions in children and adolescents with major depressive disorder",
        "Low episodic memory performance as a premorbid marker of depression: Evidence from a 3-year follow-up",
        "A 35-year longitudinal assessment of cognition and midlife depression symptoms: The vietnam era twin study of aging",
        "Impairment of executive function and attention predicts onset of affective disorder in healthy high-risk twins",
        "Towards a classification of biomarkers of neuropsychiatric disease: From encompass to compass",
        "Job performance deficits due to depression",
        "Effects of major depression on moment-in-time work performance",
        "The economic burden of depression in the United States: How did it change between 1990 and 2000?",
        "Association between severity of depression and self-perceived cognitive difficulties among full-time employees",
        "The integrative management of treatment-resistant depression: A comprehensive review and perspectives",
        "Development of a Rating Scale for Primary Depressive Illness",
        "A new depression scale designed to be sensitive to change",
        null,
        "Antidepressant drugs and the response in the placebo group: The real problem lies in our understanding of the issue",
        "The empirical redefinition of the psychometric criteria for remission in bipolar disorder",
        "The relationship of health-related quality of life and treatment outcome during inpatient treatment of depression",
        "The Factors Influencing Depression Endpoints Research (FINDER) study: Final results of Italian patients with depression",
        "Using measurement strategies to identify and monitor residual symptoms",
        "Cognitive dysfunction in unipolar depression: Implications for treatment",
        "Hippocampal volume, memory, and cortisol status in major depressive disorder: Effects of treatment",
        "Mood and neuropsychological changes in women with midlife depression treated with escitalopram",
        "Psychomotor changes in major depressive disorder during sertraline treatment",
        "Effects of sertraline on depressive symptoms and attentional and executive functions in major depression",
        "Antidepressant use and cognitive functioning in older medical patients with major or minor depression: A prospective cohort study with database linkage",
        "The effect of bupropion XL and escitalopram on memory and functional outcomes in adults with major depressive disorder: Results from a randomized controlled trial",
        "Bupropion normalizes cognitive performance in patients with depression",
        "Enhancing effect of mirtazapine on cognitive functions associated with prefrontal cortex in patients with recurrent depression.",
        "Effect of tianeptine on cognitive functions in patients with depressive disorders during a 3-month observation",
        "Major Depressive Disorder in recovery and neuropsychological functioning: Effects of selective serotonin reuptake inhibitor and dual inhibitor depression treatments on residual cognitive deficits in patients with Major Depressive Disorder in recovery",
        "Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: An 8-week, double-blind, placebo-controlled trial",
        "Does duloxetine improve cognitive function independently of its antidepressant effect in patients with major depressive disorder and subjective reports of cognitive dysfunction?",
        "A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder",
        "Cognitive effects of pharmacotherapy for major depressive disorder: A systematic review",
        "Psychomotor slowing as a predictor of fluoxetine nonresponse in depressed outpatients",
        "Neurocognitive predictors of antidepressant clinical response",
        "Neurocognitive correlates of response to treatment in late-life depression",
        "Executive dysfunction and long-term outcomes of geriatric depression",
        "Reducing suicidal ideation and depression in older primary care patients: 24-Month outcomes of the PROSPECT study",
        "Prefrontal neuropsychological predictors of treatment remission in late-life depression",
        "The depression-executive dysfunction (DED) syndrome and response to antidepressants: A meta-analytic review",
        "A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Melbourne",
            "affilname": "University of Melbourne",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Fortaleza",
            "affilname": "Universidade Federal do Cear\u00e1",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Geelong",
            "affilname": "Deakin University",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Porto Alegre",
            "affilname": "Universidade Federal do Rio Grande do Sul",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Copenhagen",
            "affilname": "Rigshospitalet",
            "affiliation-country": "Denmark"
        },
        {
            "affiliation-city": "Padua",
            "affilname": "Universit\u00e0 degli Studi di Padova",
            "affiliation-country": "Italy"
        }
    ],
    "funding": [
        "Conselho Nacional de Desenvolvimento Cient\u00edfico e Tencnol\u00f3gico",
        "National Health and Medical Research Council",
        "National Health and Medical Research Council",
        "Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior",
        "Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico"
    ]
}